Atlas Trials

The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy

Clinical trial NCT03073031 · COMPLETED

Trial details

NCT number
NCT03073031
Sponsor
Odense University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Adverse Effects
Start date
2017-01-10
Primary completion
2019-11-01
Enrollment
146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.